ArticleWorld journal of gastroenterology2017

Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease.

Latha Paka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.